Navigation Links
Pfizer Animal Health and NTRA Charities Team Up to Benefit the Barbaro Memorial Fund
Date:1/31/2008

Promotions Support Fund's Goal of Finding a Cure for Laminitis

NEW YORK, Jan. 31 /PRNewswire/ -- Pfizer Animal Health and the National Thoroughbred Racing Association (NTRA) have joined forces to help fund laminitis research through the NTRA Charities - Barbaro Memorial Fund. The partnership's aim is to increase awareness of the Fund across the horse industry and encourage further support of cutting edge research into laminitis prevention and treatment.

Owners, trainers and horse enthusiasts alike can contribute directly to the work of the Barbaro Memorial Fund online at RidingwithBarbaro.org. Information on the donation site, and the Fund's goal, will be featured in 2008 Pfizer Animal Health advertising for several equine products, as well as on displays in select retail outlets across the country and at major equine events. Riding with Barbaro awareness bracelets will be available as part of select display promotions.

"Laminitis is a potentially devastating disease that affects horses at all levels of equine sports and across disciplines -- from great Thoroughbred champions like Barbaro, right on to recreational horses loved by their riders and owners," said Kristin Ruff, marketing manager, U.S. equine business, at Pfizer Animal Health. "We wanted to help raise awareness of the Fund's mission and encourage all kinds of horse people to donate what they can toward finding a cure."

"Pfizer's generous contribution and commitment to promote the NTRA Charities - Barbaro Memorial Fund will help further his legacy, both as a courageous and gifted racehorse and as the inspiration for promising new research on equine health," said Alex Waldrop, president and CEO of the NTRA.

The entire horse industry, and horse enthusiasts around the world, watched Barbaro's story unfold after his tragic injury during the 2006 Preakness Stakes. Despite the heroic efforts of a team of leading veterinarians at the University of Pennsylvania's New Bolton Center, it was laminitis that finally ended Barbaro's life in January 2007. While Barbaro will always be remembered for his courage -- both on the track and while facing injury -- his owners wanted his legacy to benefit all horses.

"Gretchen and I hope Barbaro's memory can be carried on through advances in medical research, including a cure for laminitis," said Barbaro's owner, Roy Jackson.

More information on Barbaro's legacy, as well as how to get involved with the Barbaro Memorial Fund and make a donation, can be found online at RidingwithBarbaro.org.

Formed in 1999 as a subsidiary of the National Thoroughbred Racing Association (NTRA), NTRA Charities is a nonprofit, 501 (c) (3) public charity. NTRA Charities works to improve the communities that are home to Thoroughbred racing and to ensure the health and safety of the sport's human and equine athletes.

Pfizer, Inc. (NYSE: PFE), the world's largest research-based biomedical and pharmaceutical company, also is a world leader in discovering and developing innovative animal vaccines and prescription medicines. Pfizer Animal Health is dedicated to improving the safety, quality and productivity of the world's food supply by enhancing the health of livestock and poultry; and in helping horses and pets to live longer and healthier lives. For additional information on Pfizer's portfolio of equine products, visit http://www.PfizerAH.com.


'/>"/>
SOURCE Pfizer Animal Health
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
2. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
3. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
4. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
5. Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007
6. Merial to Screen Chimerix Chemical Library for Animal Health Drug Leads
7. Study Shows Coronado Biosciences Bcl-2 Inhibitor, Apogossypol, is More Efficacious, Less Toxic than Gossypol in Animal Models
8. Start Licensing, Inc. Welcomes FDAs Finding of Safety of Food From Cloned Animals
9. Animal Protection Groups Condemn FDAs Endorsement of Animal Cloning
10. Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally
11. Smithfield Foods, Inc. Statement Regarding Animal Cloning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... for the Semiconductor, MEMS, and Microfluidics Industries, announces the new Model 800E front ... more often in automated production mask aligners. OAI has already received and ...
(Date:8/16/2017)... ... August 16, 2017 , ... Tunnell Consulting announced today that ... ISPE Annual Meeting and Expo , to be held October 29 through November ... is “Driving innovation to advance patient therapies.” , The ISPE Annual Meeting and Expo ...
(Date:8/16/2017)... Philadelphia, PA (PRWEB) , ... August 16, 2017 , ... ... thought, they are much more closely connected than one might think. A Mesh ... Grizzly, will open at the University City Science Center’s Esther Klein Gallery (EKG) on ...
(Date:8/16/2017)... Mass. , Aug. 16, 2017  This year,s edition of the ... leader in life sciences workforce solutions, has made the list for the ... 5000 recognizes the nation,s fastest-growing private companies based on a set of ... 50, which includes the fastest-growing companies in the Bay State ... Inc. 5000 ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):